Author: Genmab A/S

Posted Date:

May 7, 2026

Genmab Announces Financial Results for the First Quarter of 2026

Genmab A/S

May 7, 2026
Major Shareholder Announcement

Genmab A/S

April 14, 2026
Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2026

Genmab A/S

April 14, 2026
Major Shareholder Announcement

Genmab A/S

April 1, 2026
Major Shareholder Announcement

Genmab A/S

March 30, 2026
Genmab Publishes 2025 Annual Report

Genmab A/S

February 17, 2026